Greenlight Biosciences Holdings, Pbc (GRNA) SEC Filing 8-K Material Event for the period ending Thursday, August 11, 2022

Greenlight Biosciences Holdings, Pbc

CIK: 1822691 Ticker: GRNA

View differences made from one to another to evaluate Greenlight Biosciences Holdings, Pbc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Greenlight Biosciences Holdings, Pbc.


Assess how Greenlight Biosciences Holdings, Pbc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Greenlight Biosciences Holdings, Pbc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Greenlight Biosciences Holdings, Pbc provided additional information to their SEC Filing as exhibits

Ticker: GRNA
CIK: 1822691
Form Type: 8-K Corporate News
Accession Number: 0001193125-22-221367
Submitted to the SEC: Mon Aug 15 2022 6:07:19 PM EST
Accepted by the SEC: Mon Aug 15 2022
Period: Thursday, August 11, 2022
Industry: Biological Products No Disgnostic Substances
  1. Financial Exhibit
  2. New Agreement
  3. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: